Engineered T cells to treat lupus arrive on the scene

Tsokos, G. C. (2022). Engineered T cells to treat lupus arrive on the scene. Nature, 611, 456-458.

Last updated on 02/17/2024

Recent Publications

Reverse aging to treat lupus.
The immunology of systemic lupus erythematosus.
Targeting IL-1 controls refractory pityriasis rubra pilaris.
The PP2A regulatory subunit PPP2R2A controls NAD+ biosynthesis to regulate T cell subset differentiation in systemic autoimmunity.
The thymocyte-specific RNA-binding protein Arpp21 provides TCR repertoire diversity by binding to the 3'-UTR and promoting Rag1 mRNA expression.
Lupus Nephritis Biomarkers: A Critical Review

george-tsokos

Twitter

Tsokos lab has focused on the cellular and molecular pathogenesis of systemic lupus erythematosus (SLE). Our laboratory has opened and led the field of molecular abnormalities on immune cells in patients with SLE.

Secondary menu

About
Research
News

Powered byOpenScholar^®Admin Login